Upregulation of Bcl-xL protein by ginseng administration has been reported in various brain-associated disease models including bacterial inflammation, cerebral ischemia, and spinal cord injury [109,110,111,112,113]. The gene discussed is BCL2L1; the disease is brain ischemia.